Eriodictyol-7-O-glucoside, a novel Nrf2 activator, confers protection against cisplatin-induced toxicity

Food and Chemical Toxicology

Volumn 50, Issue 6, 2012, Pages 1927-1932

  Hu, Qingwen ^a   Zhang, Donna D ^b   Wang, Limei ^a   Lou, Hongxiang ^a   Ren, Dongmei ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Activate; Cisplatin; Eriodictyol 7 O glucoside; Nrf2; Toxicity

Indexed keywords

CISPLATIN; ERIODICTYOL 7 O GLUCOSIDE; FLAVONOID; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; FEASIBILITY STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MESANGIUM CELL; OXIDATION REDUCTION STATE; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN STABILITY; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CISPLATIN; FLAVANONES; GENES, REPORTER; GLUTATHIONE; HALF-LIFE; HUMANS; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION;

DRACOCEPHALUM;

EID: 84860165159     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.03.059     Document Type: Article

References (31)

1. Aleksunes L.M., Goedken M.J., Rockwell C.E., Thomale J., Manautou J.E., Klaassen C.D. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J. Pharmacol. Exp. Ther. 2010, 335:2-12.
2. Chatzopoulou A., Karioti A., Gousiadou C., Lax Vivancos V., Kyriazopoulos P., Golegou S., Skaltsa H. Depsides and other polar constituents from Origanum dictamnus L. and their in vitro antimicrobial activity in clinical strains. J. Agric. Food Chem. 2010, 58:6064-6068.
3. Conklin K.A. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr. Cancer 2000, 37:1-18.
4. Dillioglugil M.O., Maral Kir H., Gulkac M.D., Ozon Kanli A., Ozdogan H.K., Acar O., Dillioglugil O. Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats. Urol. Int. 2005, 75:340-344.
5. Du Y., Villeneuve N.F., Wang X.J., Sun Z., Chen W., Li J., Lou H., Wong P.K., Zhang D.D. Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ. Health Perspect. 2008, 116:1154-1161.
6. Fram R.J. Cisplatin and platinum analogues: recent advances. Curr. Opin. Oncol. 1992, 4:1073-1079.
7. Gao S.S., Choi B.M., Chen X.Y., Zhu R.Z., Kim Y., So H., Park R., Sung M., Kim B.R. Kaempferol suppresses cisplatin-induced apoptosis via inductions of heme oxygenase-1 and glutamate-cysteine ligase catalytic subunit in HEI-OC1 cell. Pharm. Res. 2010, 27:235-245.
8. Guerrero-Beltran C.E., Calderon-Oliver M., Tapia E., Medina-Campos O.N., Sanchez-Gonzalez D.J., Martinez-Martinez C.M., Ortiz-Vega K.M., Franco M., Pedraza-Chaverri J. Sulforaphane protects against cisplatin-induced nephrotoxicity. Toxicol. Lett. 2010, 192:278-285.
9. Keum Y.S. Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications. Ann. NY Acad. Sci. 2011, 1229:184-189.
10. Kopke R.D., Liu W., Gabaizadeh R., Jacono A., Feghali J., Spray D., Garcia P., Steinman H., Malgrange B., Ruben R.J., Rybak L., Van de Water T.R. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am. J. Otol. 1997, 18:559-571.
11. Lau A., Villeneuve N.F., Sun Z., Wong P.K., Zhang D.D. Dual roles of Nrf2 in cancer. Pharmacol. Res. 2008, 58:262-270.
12. Li J., Johnson D., Calkins M., Wright L., Svendsen C., Johnson J. Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol. Sci. 2005, 83:313-328.
13. Liu K., Cho Y.Y., Yao K., Nadas J., Kim D.J., Cho E.J., Lee M.H., Pugliese A., Zhang J., Bode A.M., Dong Z. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. J. Biol. Chem. 2011, 286:2057-2066.
14. Ramon Sanchez de Rojas V., Somoza B., Ortega T., Villar A.M., Tejerina T. Vasodilatory effect in rat aorta of eriodictyol obtained from Satureja obovata. Planta Med. 1999, 65:234-238.
15. Ren D.M., Guo H.F., Wang S.Q., Lou H.X. Separation and structure determination of two diastereomeric pairs of enantiomers from Dracocephalum rupestre by high-performance liquid chromatography with circular dichroism detection. J. Chromatogr. A 2007, 1161:334-337.
16. Ren D.M., Guo H.F., Yu W.T., Wang S.Q., Ji M., Lou H.X. Stereochemistry of flavonoidal alkaloids from Dracocephalum rupestre. Phytochemistry 2008, 69:1425-1433.
17. Ren D.M., Qu Z., Wang X.N., Shi J., Lou H.X. Simultaneous determination of nine major active compounds in Dracocephalum rupestre by HPLC. J. Pharm. Biomed. Anal. 2008, 48:1441-1445.
18. Rossato M.F., Trevisan G., Walker C.I., Klafke J.Z., de Oliveira A.P., Villarinho J.G., Zanon R.B., Royes L.F., Athayde M.L., Gomez M.V., Ferreira J. Eriodictyol: a flavonoid antagonist of the TRPV1 receptor with antioxidant activity. Biochem. Pharmacol. 2011, 81:544-551.
19. Sahin K., Sahin N., Kucuk O. Lycopene and chemotherapy toxicity. Nutr. Cancer 2010, 62:988-995.
20. Sahin K., Tuzcu M., Gencoglu H., Dogukan A., Timurkan M., Sahin N., Aslan A., Kucuk O. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 2010, 87:240-245.
21. Sahin K., Tuzcu M., Sahin N., Ali S., Kucuk O. Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem. Toxicol. 2010, 48:2670-2674.
22. Schaaf G.J., Maas R.F., de Groene E.M., Fink-Gremmels J. Management of oxidative stress by heme oxygenase-1 in cisplatin-induced toxicity in renal tubular cells. Free Radic. Res. 2002, 36:835-843.
23. So H.S., Kim H.J., Lee J.H., Park S.Y., Park C., Kim Y.H., Kim J.K., Lee K.M., Kim K.S., Chung S.Y., Jang W.C., Moon S.K., Chung H.T., Park R.K. Flunarizine induces Nrf2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin. Cell Death Differ. 2006, 13:1763-1775.
24. Thimmulappa R.K., Mai K.H., Srisuma S., Kensler T.W., Yamamoto M., Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 2002, 62:5196-5203.
25. Urcan E., Haertel U., Styllou M., Hickel R., Scherthan H., Reichl F.X. Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. Dent. Mater. 2010, 26:51-58.
26. Wang J., He D., Zhang Q., Han Y., Jin S., Qi F. Resveratrol protects against cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biother. Radiopharm. 2009, 24:675-680.
27. Xiao T., Choudhary S., Zhang W., Ansari N.H., Salahudeen A. Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J. Toxicol. Environ. Health A 2003, 66:469-479.
28. Yao H., Liao Z.X., Wu Q., Lei G.Q., Liu Z.J., Chen D.F., Chen J.K., Zhou T.S. Antioxidative flavanone glycosides from the branches and leaves of Viscum coloratum. Chem. Pharm. Bull. (Tokyo) 2006, 54:133-135.
29. Yousef M.I., Saad A.A., El-Shennawy L.K. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem. Toxicol. 2009, 47:1176-1183.
30. Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 2006, 38:769-789.
31. Zhang D.D., Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 2003, 23:8137-8151.